Detalhe da pesquisa
1.
Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab.
Cancer Immunol Immunother
; 71(11): 2791-2799, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35435450
2.
A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer.
BMC Cancer
; 14: 231, 2014 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24678902
3.
Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504).
BMC Cancer
; 12: 301, 2012 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22817667
4.
Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study.
Target Oncol
; 17(6): 675-682, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36129569
5.
Evidence of slight improvement in five-year survival in non-small-cell lung cancer over the last 10 years: Results of the French KBP-CPHG real-world studies.
Bull Cancer
; 106(4): 283-292, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30803715
6.
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study.
Lung Cancer
; 137: 149-156, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31600593
7.
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.
Lancet Haematol
; 6(1): e48-e57, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30528137
8.
Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group.
J Thorac Dis
; 9(10): 3747-3754, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29268382
9.
Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.
J Clin Oncol
; 34(13): 1476-83, 2016 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26884557
10.
Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: a prospective multicenter study in a real-world setting (GFPC study 12-01).
Lung Cancer
; 86(2): 170-3, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25214431
11.
Cost analysis of erlotinib versus chemotherapy for first-line treatment of non-small-cell lung cancer in frail elderly patients participating in a prospective phase 2 study (GFPC 0505).
Clin Lung Cancer
; 14(2): 103-7, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22682669
12.
Cost-effectiveness of second-line chemotherapy for non-small cell lung cancer: an economic, randomized, prospective, multicenter phase III trial comparing docetaxel and pemetrexed: the GFPC 05-06 study.
J Thorac Oncol
; 6(1): 161-8, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21150465
13.
Pseudo-outbreak of Pseudomonas putida Respiratory Infection Caused by Laboratory Contamination.
Infect Control Hosp Epidemiol
; 32(5): 523-5, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21515992